
Alzheimer’s is the most common type of dementia. Dementia is the progressive decline in congnitive function due to damage or disease in the brain, beyond what might be expected from normal aging. However, there are several other types that can affect memory, attention, problem solving, and language.
Multi-infarct or Vascular Dementia (VD) is the second most common type of dementia. It is caused by lesions in the brain’s blood vessels. People who have suffered strokes are 9 times more likely to develop this type of dementia than people who have not had a stroke. Vascular dementia is more common among men and the risk for it increases with age. Other risk factors include hypertension, smoking, diabetes, cardiovascular disease, and high cholesterol.
The disease initially begins by affecting the patient’s cognitive and motor abilities, and behavior. Often patients become apathetic, disoriented and experience urinary incontinence.
The best way to manage the disease is by preventing further lesions in the brain. Antiplatelet drugs and controlling the risk factors (hypertension, cholesterol, smoking, ect.) can be successful in managing the progression of the disease.
Dementia with Lewy Bodies (DLB) is a mixture of Alzheimer’s and Parkinson’s. It is characterized by abnormal protein clumps found throughout the brain, which are called “Lewy Bodies”. These bodies are similar to what is found in the brains of Parkinson’s patients. Patients with this type of dementia also experience a loss of neurons, similar to what is found in Alzheimer’s patients.
The symptoms of DLB includes cognitive decline, memory impairment, vision problems, loss of alertness and attention, hallucinations, Parkinson-like tremors, loss of consciousness, and sleep disturbance.
Treatment is difficult because when treating motor problems, hallucinations worsen and when treating hallucinations, tremors worsen. So a balance must be struck between motor and cognitive symptoms by balancing out antipsychotic drugs and cholinesterase inhibitors.
FTLD is another type of dementia. There are three variations of FTLD:
Creutzfeldt-Jakob disease (CJD) is caused by a unique infectious agent called a prion, an abnormal protein. Other prion diseases include scrapie, Mad Cow disease, and chronic wasting disease. The prions kill the brain’s normal nerve cells. Under a microscope, tiny holes can be seen, giving the brain a “spongy” appearance.
This rare disease affects only 1 in 1 million people, generally aged 60-65, per year. In more than 85 percent of cases, patients with CJD live less than a year after the initial onset of symptoms. Symptoms are rapid dementia, memory loss, personality changes and hallucinations. These are accompanied with physical symptoms such as jerky motions, changes in gait, seizures, rigid posture, and balance and coordination problems.
As of September 2006, there is no cure for CJD. It is a fatal disease and the search for treatments continues.
Huntington’s is a rare inherited neurological disorder affecting up to 8 people per 100,000. It is first noticed by physical symptoms, such as jerky, random, uncontrollable movements. It can lead to cognitive and psychiatric problems. Children of people with Huntington’s have a 50 percent chance of inheriting the disease. There is a blood test that can show whether a person has the gene for the disease or not. It can be managed through medication, nutrition, and therapy.
Parkinson’s is a degenerative disorder that affects the central nervous system. Symptoms include: tremor, problems with gait, impaired ability to swallow, mood disturbances, slow reaction time, sleep disturbances, sensation disturbances, and other adverse health affects. Dementia develops later in only about 20-40 percent of all patients.
Source: Wikipedia Online Encyclopedia: http://en.wikipedia.org/wiki/Dementia